AxoGen (AXGN) Debt/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | -0.79 | -0.79 | -2.87 | 5.79 | -84.9 | -10.9 | ||
| Changes by years, y/y, % | 0% | +262% | -302% | -1 567% | ||||
AxoGen. Debt/EBITDA
AxoGen. Debt/EBITDA, changes, %
AxoGen (AXGN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 5.28 | 2.98 | 1.49 | -1.85 | -10.9 | -10.9 | ||
| Changes by years, y/y, % | -202% | -113% | -94% | -132% | -306% | |||
| Changes by quarters, q/q, % | -9% | -44% | -50% | -224% | +489% | |||